大数跨境

Protheragen Will Attend the SAPA-CT 2024 Annual Conference

Protheragen Will Attend the SAPA-CT 2024 Annual Conference Protheragen
2024-12-02
2
导读:12月7日,我们耶鲁大学见!








参会邀请

美东时间12月7日周六,美中药协康涅狄格州分会(SAPA-CT)将在耶鲁大学举办2024 SAPA-CT十一周年年会!本届年会以“医药创新:未来已来”为主题,为广大参会者呈现精彩内容。


作为赞助商之一,Protheragen Inc. 十分期待与各位业界精英会上相聚,一同聆听来自医药领域的顶级科学家、企业高管、机构代表的独特见解,与各位领袖共同探讨生物医药领域的挑战和发展策略。欢迎到我们的C区展位上交流职业发展和项目合作机会!




1

会议信息


Event Theme

New Era of Innovation in Biomedicine

Main Topics

Cutting-edge Technology in Drug Discovery

Accelerating Drug Discovery by Big Data Al

New Trends in Translational Medicine

Career Development Workshop

Startup Pitch Contest

Event Date

Dec. 7, 2024 Sat.8:30am-5:30pm

Event Location

TAC Auditorium, Yale University, 300 Cedar Street, New Haven, CT 06511, USA


2 年会日程及嘉宾名单

8:00-8:30 am

Registration and Welcome

8:30-8:45 am

Welcome Speech

Lily Li, Ph.D, President of SAPA-CT

Chao Zheng,Ph.D, Immediate past president of SAPA-CT

8:45-9:00 am

Opening Address by William Tong

9:00-9:30 am

Prof. Haifan Lin

9:30-9:55 am

Peter Marks, Ph.D

Presentation title: Accelerating the Pace for Biologic Products

10:35-11:00 am

Peter Luo, Ph.D 

Presentation title: A New Paradigm in Targeting CTLA4 for Unmet Medical Needs

11:00-11:25 am

Ke Cheng, Ph.D

Presentation title: Novel Exosome Therapeutics

11:25 -11:45 am

Harris Zhang, Ph.D

Presentation title: Ultra-sensitive Multiplex Bioassays to Accelerate Drug Discovery and Translational Development

11:45 am-12:05 pm

Daozhan Yu, Ph.D

Presentation Title: New Technologies to Enhance AAV Gene Therapy Efficiency

1:30-1:55 pm

James Cai, Ph.D

Presentation title: AI in drug discovery: looking beyond the hype

1:55-2:20 pm

Zhiyong Xie, Ph.D

Presentation Title: From Organ to Cell, Leverage Imaging and AI Technologies To Accelerate Drug Development

2:20-2:45 pm

Kenji Fujita, Ph.D (Atsena CMO) 

Speech

2:45-3:30 pm

Phillippe Mourere, PharmD, Ph.D. (NanoMosaic, CEO)

Panel discussion

2:45-3:30 pm

Eric Sigel, Ph.D (Signel IX LLC, Principal)

Panel discussion

2:45-3:30 pm

Niven Narain, Ph.D (BPGbio Inc, President & CEO)

Panel discussion


2:45-3:30 pm

Hanrui (Raye) Zhang, Ph.D (FDA, AL/ML Reviewer/Researcher)

Panel discussion




3

联系我们


Protheragen Inc. 成立于2009年,总部位于美国纽约州长岛,经过十余年发展,已成长为一家集生物技术和医药项目投资、孵化、开发、转让为一体的集团公司。

目前,我们致力于在生物技术领域开发新的产品、落地独特技术平台。我们在美国纽约长岛拥有独立实验大楼,且在持续扩大建设。我们也拥有推广和销售体系,亟待开发新的产品和落地独特技术平台。

欢迎拥有下述领域生物技术项目或者有合作需求的业界专家联系我们,商谈合作开发、事业共享的机会。

 

分子生物学

 

蛋白工程

 

细胞生物学

 

基因治疗

 

抗体工程

公司内部招募请点击 这里

Send your resume and BP to 

contact@protheragen.com

END

【声明】内容源于网络
0
0
Protheragen
1234
内容 74
粉丝 0
Protheragen 1234
总阅读212
粉丝0
内容74